CVS Health Co. (NYSE:CVS) Stock Position Lowered by Nicolet Advisory Services LLC

Nicolet Advisory Services LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 39.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 7,573 shares of the pharmacy operator’s stock after selling 4,895 shares during the period. Nicolet Advisory Services LLC’s holdings in CVS Health were worth $364,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CVS. Arete Wealth Advisors LLC purchased a new stake in shares of CVS Health in the third quarter worth approximately $1,369,000. Janus Henderson Group PLC lifted its position in CVS Health by 370.6% in the 3rd quarter. Janus Henderson Group PLC now owns 760,903 shares of the pharmacy operator’s stock worth $47,825,000 after buying an additional 599,200 shares in the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of CVS Health during the 3rd quarter valued at $7,233,000. Morse Asset Management Inc purchased a new position in shares of CVS Health during the 3rd quarter valued at $409,000. Finally, Royal London Asset Management Ltd. increased its stake in shares of CVS Health by 4.1% in the third quarter. Royal London Asset Management Ltd. now owns 520,107 shares of the pharmacy operator’s stock worth $32,704,000 after acquiring an additional 20,679 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other news, SVP James David Clark sold 7,513 shares of the company’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michael F. Mahoney purchased 30,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the completion of the acquisition, the director now directly owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.24% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on CVS shares. Evercore ISI upped their target price on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research report on Monday, January 27th. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Thursday, February 13th. Argus set a $77.00 price target on shares of CVS Health in a research note on Tuesday, February 18th. Wells Fargo & Company raised their price target on shares of CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Finally, Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.39.

CVS Health Stock Down 5.9 %

CVS opened at $63.54 on Friday. The company has a market capitalization of $80.11 billion, a P/E ratio of 17.36, a P/E/G ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The firm’s fifty day moving average price is $63.47 and its two-hundred day moving average price is $58.01. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $75.12.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.19%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health’s dividend payout ratio is 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.